The Future of Pathology is led by an international panel of pathologists passionate about raising the profile of pathology in order to advance care for patients. The panel will drive a forward-thinking agenda of key issues and topics that matter to pathologists and healthcare leaders. The Future of Pathology expert panel comprises: Dr. Matthew Clarke and Dr. Bethany Williams from the UK, and Dr. Jerad Gardner and Dr. Tiffany Graham from the US.
Meet the Panel
Dr. Matthew Clarke is a histopathology trainee and clinical fellow at the Institute of Cancer Research (London, UK) working towards a PhD in ‘the molecular pathology of infant glioma.’ He graduated from the University of Liverpool with a BSc in Zoology in 2004, and achieved his MBChB from Keele University in 2010. He completed his foundation training at what is now the Royal Stoke University Hospital before gaining a core surgical training post in London where he achieved his MRCS examinations. He subsequently changed career paths and successfully became a histopathology trainee in 2013. He is very committed to and involved with the Royal College of Pathologists (RCPath) and other pathology societies; formerly a trainee councilor and now deputy meetings secretary for the British Division of the International Academy of Pathology (BDIAP), the Association of Clinical Pathologists (ACP) trainee communications officer, and the current Chair of the Trainees’ Advisory Committee (TAC) for the RCPath. As the Chair of the TAC, he has been involved in implementing an anti-bullying and harassment campaign, helping to develop the inaugural ‘Foundation Taster Day’ event to promote pathology to junior doctors, is a regular contributor to the College Bulletin publication, and also took part in a video with Professor Sir James Underwood where he discussed histopathology past, present and future. He is also an Assistant Editor for the pathology magazine, ACP News where he frequently publishes articles related to current issues in pathology. He has been very involved in teaching and public engagement work throughout his career, and was given the ‘ICR Public Engager of the Year’ award in 2017. After completion of his PhD, he is aiming to return to training in neuropathology with continued active involvement with academic and molecular pathology.
Dr. Jerad M. Gardner is a Dermatopathologist and Bone/Soft Tissue Pathologist at Geisinger Medical Center in Pennsylvania. At the time of writing the Future of Pathology Report, he was an Associate Professor of Pathology and Dermatology at the University of Arkansas for Medical Sciences (UAMS) in Little Rock, where he was also the dermatopathology fellowship program director and the musculoskeletal/skin module co-director for the College of Medicine. He obtained his MD from Tulane University in New Orleans, completed residency in anatomic and clinical pathology at Houston Methodist Hospital, and completed fellowships in bone/soft tissue pathology and dermatopathology at Emory University in Atlanta. Dr. Gardner has 100 peer-reviewed publications as well as multiple book chapters. He is also author of the book Survival Guide to Dermatopathology and co-author of the book Survival Guide to Soft Tissue Pathology. He is particularly interested in cutaneous soft tissue tumors, skin adnexal tumors, medical education, and the professional use of Twitter, Facebook, YouTube, and other social media for pathologists. He is an active volunteer member in a variety of sarcoma and other rare disease patient support groups on Facebook. He has used his relationship with these patient groups to conduct formal medical research and to advocate on behalf of their diseases (info: https://youtu.be/9aQSmx0A7pg). His work has been recognized by multiple awards, including the Resident Advocate Award (2015) and the Outstanding Communicator Award (2018) from the College of American Pathologists and the UAMS Chancellor’s Teaching Award for Teaching Excellence (2018). He was also a top five member of the 2017 “40 Under Forty” by the American Society of Clinical Pathology and was ranked first place on the 2019 Power List of pathology trailblazers issued by The Pathologist magazine. Dr. Gardner is chair of the Social Media Subcommittee and also member-at-large on the Board of Directors for the American Society of Dermatopathology. He is a Deputy Editor-in-Chief of Archives of Pathology & Laboratory Medicine.
Dr. Tiffany M. Graham is a Gastrointestinal and Hepatobiliary/Surgical Pathology Clinical Instructor at the Medical University of South Carolina in Charleston (MUSC). She obtained her MD from American University of the Caribbean (AUC) School of Medicine in 2014 then completed her anatomical and clinical pathology residency at the University of Alabama in Birmingham (UAB) in 2019. During her training, Dr. Graham created and shared hundreds of “high yield pathology” infographics on her educational website, iheartpathology.net, and on social media, where she is better known by her Twitter handle, @HeartPathology. Her visually stunning educational compositions have been honored with awards including the #PathTweetAward (2018), the Outstanding Trainee Teaching Award for Multidisciplinary and Medical Student Education (2017), and the Award for Excellence in Laboratory Medicine (2016). Dr. Graham is a member of the American Society for Clinical Pathology (ASCP) social media team on Twitter and was recently featured in articles by ASCP and ThePathologist.com for her use of Social Media in pathology education.
Dr. Bethany Williams is a Digital Pathology Research Fellow at Leeds Teaching Hospitals NHS Trust and the University of Leeds, where she is a lead investigator on the Northern Pathology Imaging Co-Operative, investigating the clinical adoption of artificial intelligence in pathology. She obtained her medical degree at University College London before commencing histopathology training at Leeds. In 2015, she became the world’s first Leadership Fellow in Digital Pathology, designed and project managed Leeds’ innovative digital pathology pilot deployment and validation. She is now reaching the end of a PhD focused on patient safety aspects of digital pathology technology, and has published extensively on diverse digital pathology topics including the case for adoption and the business case for digital pathology deployment. She is a thought leader in evidence based digital pathology training and validation, and her scientific papers on digital diagnostic accuracy form the basis of the Royal College of Pathologists’ guidelines for safe, effective digital deployment. Her body of research earned her the Pathological Society’s medal for research impact, and she is regularly invited to speak at international conferences as an authority on the digital pathology evidence base, practical deployment and patient safety.